MONOCLONAL ANTIBODIES

Michigan residents who are dealing with a COVID-19 infection can now search for potential treatment options near them.

We now have many drugs to help protect the most vulnerable from becoming seriously ill from COVID.

Treatments for people who have become infected with COVID are also being touted by officials as another way for us to reduce the toll COVID-19 is exacting.

State officials say their supply of monoclonal antibodies is good enough right now. Still, the demand is high as hospitals struggle to make it available to patients who desperately need it.

Cynthia Canty spent decades both on radio and TV as a trusted anchor, reporter and host.

Henry Ford Health System announced Thursday it is partnering with the Michigan Department of Health and Human Services to increase access to monoclonal antibody treatments.

Michigan Gov. Gretchen Whitmer announced Wednesday the state would be expanding its use of COVID treatments in an effort to combat rising hospitalizations.

The safety and effectiveness of Regeneron’s antibody treatment have not yet been proven. Regeneron announced Wednesday that it has submitted an Emergency Use Authorization request to the U.S. Food and Drug Administration for its COVID-19 antibody treatment. The company says that if the drug is approved, the government has committed to making the drug available to Americans at no cost. Trump has explicitly that he would like to make the drug available and free for everyone. Regeneron says they currently have doses of the drug available for about 50,000 patients and expect to have enough for 300,000 patients within the coming months.